{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:40:01Z","timestamp":1753886401883,"version":"3.37.3"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,7]]},"DOI":"10.1093\/cid\/ciab205","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T04:10:26Z","timestamp":1614399026000},"page":"873-875","source":"Crossref","is-referenced-by-count":2,"title":["Shortening the Duration of Therapy for <i>Staphylococcus aureus<\/i> Bacteremia: Opening the Overton Window"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1368-8356","authenticated-orcid":false,"given":"Steven Y C","family":"Tong","sequence":"first","affiliation":[{"name":"Victorian Infectious Diseases Service, The Royal Melbourne Hospital, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia"},{"name":"Department of Infectious Diseases, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Walls","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Middlemore Hospital, Counties Manukau Health, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"2021090720251095100_CIT0001","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2021090720251095100_CIT0002","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021090720251095100_CIT0003","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/cid\/ciy1134","article-title":"Short-course antibiotic therapy-replacing Constantine units with \u201cShorter Is Better\u201d","volume":"69","author":"Wald-Dickler","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021090720251095100_CIT0004","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021090720251095100_CIT0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2021090720251095100_CIT0006","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa114","article-title":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK","author":"Brown","year":"2021","journal-title":"JAC-Antimicrobial Resistance"},{"key":"2021090720251095100_CIT0007","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/cid\/ciz984","article-title":"The Overton window and a less dogmatic approach to antibiotics","volume":"70","author":"Morgan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021090720251095100_CIT0008","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3357-9","article-title":"Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial","volume":"20","author":"Thorlacius-Ussing","year":"2019","journal-title":"Trials"},{"key":"2021090720251095100_CIT0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/jamainternmed.2017.7947","article-title":"Immortal time bias in assessing evidence-based care processes for Staphylococcus aureus bacteremia","volume":"178","author":"Tong","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2021090720251095100_CIT0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ije\/dyl263","article-title":"Survival-related biases survive well","volume":"36","author":"Saracci","year":"2007","journal-title":"Int J Epidemiol"},{"key":"2021090720251095100_CIT0011","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"2021090720251095100_CIT0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"key":"2021090720251095100_CIT0013","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/AAC.01021-12","article-title":"Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study","volume":"57","author":"Chong","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021090720251095100_CIT0014","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmi.2018.09.018","article-title":"Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteraemia: a cohort study","volume":"25","author":"Kim","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2021090720251095100_CIT0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cmi.2019.07.019","article-title":"Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study","volume":"26","author":"Abbas","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021090720251095100_CIT0016","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2018.13155","article-title":"Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with Staphylococcal bacteremia: a randomized clinical trial","volume":"320","author":"Holland","year":"2018","journal-title":"JAMA"},{"key":"2021090720251095100_CIT0017","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.cmi.2020.01.003","article-title":"Duration of antibiotic therapy for Staphylococcus aureus bacteraemia: the long and the short of it","volume":"26","author":"Eichenberger","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2021090720251095100_CIT0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(86)90180-4","article-title":"Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia","volume":"81","author":"Rahal","year":"1986","journal-title":"Am J Med"},{"key":"2021090720251095100_CIT0019","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12879-020-05132-1","article-title":"Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial (SATIE)","volume":"20","author":"Olmos","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2021090720251095100_CIT0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2020.05.012","article-title":"Accelerated treatment of endocarditis\u2014the POET II trial: rationale and design of a randomized controlled trial","volume":"227","author":"\u00d8stergaard","year":"2020","journal-title":"Am Heart J"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab205\/37510567\/ciab205.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/5\/873\/40326179\/ciab205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/5\/873\/40326179\/ciab205.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T20:27:56Z","timestamp":1631046476000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/5\/873\/6155929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3,2]]},"published-print":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab205","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,3,2]]}}}